NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE
NAD is a Ligand Of Interest in 8HSA designated by the Author
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with same target (top 5) |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
| 8HSA_NAD_A_401 | 74% | 30% | 0.092 | 0.923 | 1.16 | 1.52 | 6 | 9 | 1 | 0 | 100% | 1 |
| 8HSA_NAD_D_401 | 69% | 27% | 0.095 | 0.911 | 1.26 | 1.57 | 7 | 8 | 1 | 0 | 100% | 1 |
| 8HSA_NAD_C_401 | 68% | 29% | 0.096 | 0.909 | 1.19 | 1.55 | 6 | 11 | 3 | 0 | 100% | 1 |
| 8HSA_NAD_F_401 | 63% | 30% | 0.111 | 0.908 | 1.2 | 1.5 | 5 | 8 | 2 | 0 | 100% | 1 |
| 8HSA_NAD_G_401 | 58% | 27% | 0.107 | 0.886 | 1.21 | 1.6 | 6 | 10 | 0 | 0 | 100% | 1 |
| 8HSA_NAD_B_401 | 41% | 27% | 0.126 | 0.839 | 1.27 | 1.59 | 8 | 9 | 2 | 0 | 100% | 1 |
| 8HSA_NAD_E_401 | 34% | 27% | 0.126 | 0.81 | 1.17 | 1.67 | 6 | 10 | 5 | 0 | 100% | 1 |
| 8HSA_NAD_H_401 | 7% | 30% | 0.174 | 0.634 | 1.17 | 1.52 | 5 | 9 | 2 | 0 | 100% | 1 |
| 8HS4_NAD_B_401 | 57% | 29% | 0.112 | 0.886 | 1.18 | 1.53 | 6 | 10 | 0 | 0 | 100% | 1 |
| 8HS5_NAD_A_401 | 37% | 31% | 0.125 | 0.822 | 1.2 | 1.43 | 5 | 9 | 2 | 0 | 100% | 1 |
| 1DBV_NAD_O_336 | 100% | 18% | 0.012 | 0.999 | 1.39 | 1.98 | 5 | 12 | 0 | 0 | 100% | 1 |
| 1HZJ_NAD_A_400 | 100% | 22% | 0.009 | 0.999 | 1.43 | 1.7 | 8 | 8 | 1 | 0 | 100% | 1 |
| 1OWB_NAD_A_3000 | 100% | 7% | 0.015 | 0.998 | 2.36 | 2.37 | 10 | 13 | 1 | 0 | 100% | 1 |
| 2NAD_NAD_B_394 | 100% | 7% | 0.016 | 0.997 | 2.25 | 2.54 | 14 | 23 | 3 | 0 | 100% | 1 |
| 2QG4_NAD_F_500 | 100% | 19% | 0.017 | 0.998 | 1.81 | 1.58 | 4 | 9 | 0 | 0 | 100% | 1 |